United Therapeutics Corporation is a biotechnology company that develops and commercializes unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. The company focuses primarily on pulmonary arterial hypertension and other pulmonary diseases, manufacturing and marketing FDA-approved therapies including Remodulin, Treprostinil, Orenitram, and Unituxin. United Therapeutics also conducts research in organ manufacturing technologies and xenotransplantation to address the shortage of transplantable organs.

LinkedIn ↗